Literature DB >> 18480335

Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells.

Ralf Gerhard1, Stefanie Nottrott1, Janett Schoentaube1, Helma Tatge1, Alexandra Olling1, Ingo Just1.   

Abstract

The intestinal epithelial cell line HT-29 was used to study the apoptotic effect of Clostridium difficile toxin A (TcdA). TcdA is a 300 kDa single-chain protein, which glucosylates and thereby inactivates small GTPases of the Rho family (Rho, Rac and Cdc42). The effect of TcdA-catalysed glucosylation of the Rho GTPases is well known: reorganization of the actin cytoskeleton with accompanying morphological changes in cells, leading to complete rounding of cells and destruction of the intestinal barrier function. Less is known about the mechanism by which apoptosis is induced in TcdA-treated cells. In this study, TcdA induced the activation of caspase-3, -8 and -9. Apoptosis, as estimated by the DNA content of cells, started as early as 24 h after the addition of TcdA. The impact of Rho glucosylation was obvious when mutant TcdA with reduced or deficient glucosyltransferase activity was applied. TcdA mutant W101A, with 50-fold reduced glucosyltransferase activity, induced apoptosis only at an equipotent concentration compared with wild-type TcdA at a 50% effective concentration of 0.2 nM. The enzyme-deficient mutant TcdA D285/287N was not able to induce apoptosis. Apoptosis induced by TcdA strictly depended on the activation of caspases, and was completely blocked by the pan-caspase inhibitor z-VAD-fmk. Destruction of the actin cytoskeleton by latrunculin B was not sufficient to induce apoptosis, indicating that apoptosis induced by TcdA must be due to another mechanism. In summary, TcdA-induced apoptosis (cytotoxic effect) depends on the glucosylation of Rho GTPases, but is not triggered by destruction of the actin cytoskeleton (cytopathic effect).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480335     DOI: 10.1099/jmm.0.47769-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  49 in total

1.  Autoproteolytic cleavage mediates cytotoxicity of Clostridium difficile toxin A.

Authors:  Isa Kreimeyer; Friederike Euler; Alexander Marckscheffel; Helma Tatge; Andreas Pich; Alexandra Olling; Janett Schwarz; Ingo Just; Ralf Gerhard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-11-03       Impact factor: 3.000

2.  Rational design of inhibitors and activity-based probes targeting Clostridium difficile virulence factor TcdB.

Authors:  Aaron W Puri; Patrick J Lupardus; Edgar Deu; Victoria E Albrow; K Christopher Garcia; Matthew Bogyo; Aimee Shen
Journal:  Chem Biol       Date:  2010-11-24

3.  Structure-function analysis of inositol hexakisphosphate-induced autoprocessing in Clostridium difficile toxin A.

Authors:  Rory N Pruitt; Benjamin Chagot; Michael Cover; Walter J Chazin; Ben Spiller; D Borden Lacy
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

4.  Glucosylation Drives the Innate Inflammatory Response to Clostridium difficile Toxin A.

Authors:  Carrie A Cowardin; Brianna M Jackman; Zannatun Noor; Stacey L Burgess; Andrew L Feig; William A Petri
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

5.  Enteric glial cells are susceptible to Clostridium difficile toxin B.

Authors:  Katia Fettucciari; Pamela Ponsini; Davide Gioè; Lara Macchioni; Camilla Palumbo; Elisabetta Antonelli; Stefano Coaccioli; Vincenzo Villanacci; Lanfranco Corazzi; Pierfrancesco Marconi; Gabrio Bassotti
Journal:  Cell Mol Life Sci       Date:  2016-11-28       Impact factor: 9.261

Review 6.  Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.

Authors:  Milena M Awad; Priscilla A Johanesen; Glen P Carter; Edward Rose; Dena Lyras
Journal:  Gut Microbes       Date:  2014

7.  Recombinant Mucin-Type Fusion Proteins with a Galα1,3Gal Substitution as Clostridium difficile Toxin A Inhibitors.

Authors:  Reeja Maria Cherian; Chunsheng Jin; Jining Liu; Niclas G Karlsson; Jan Holgersson
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

8.  Clostridium difficile Toxins TcdA and TcdB Cause Colonic Tissue Damage by Distinct Mechanisms.

Authors:  Nicole M Chumbler; Melissa A Farrow; Lynne A Lapierre; Jeffrey L Franklin; D Borden Lacy
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

9.  Contribution of adenosine A(2B) receptors in Clostridium difficile intoxication and infection.

Authors:  Cirle A Warren; Yuesheng Li; Gina M Calabrese; Rosemayre S Freire; Snjezana Zaja-Milatovic; Edward van Opstal; Robert A Figler; Joel Linden; Richard L Guerrant
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

10.  Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.

Authors:  Simon A Hirota; Vadim Iablokov; Sarah E Tulk; L Patrick Schenck; Helen Becker; Jimmie Nguyen; Samir Al Bashir; Tanis C Dingle; Austin Laing; Jianrui Liu; Yan Li; Jeff Bolstad; George L Mulvey; Glen D Armstrong; Wallace K MacNaughton; Daniel A Muruve; Justin A MacDonald; Paul L Beck
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.